Rocket Pharmaceuticals (RCKT) Notes Payables (2014 - 2021)
Rocket Pharmaceuticals' (RCKT) quarterly Notes Payables came in at $5.1 million in Q2 2021, up 2.33% quarter-over-quarter from $5.0 million in Q1 2021.
Rocket Pharmaceuticals (RCKT) Notes Payables (2014 - 2021) Analysis & Trends
Rocket Pharmaceuticals has disclosed Notes Payables across 3 years of filings, most recently posting $5.1 million for Q2 2021.
- Notes Payables for Q2 2021 came in at $5.1 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was $5.1 million (changed N/A YoY), and the FY2020 annual result was $4.9 million, changed N/A from the prior year.
- Notes Payables came in at $5.1 million for Q2 2021 at Rocket Pharmaceuticals, up from $5.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $5.1 million in Q2 2021 to a low of $4.8 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Rocket Pharmaceuticals | 301.08 Mn | 301.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 5.10 Mn |
| Mar 31, 2021 | 4.99 Mn |
| Dec 31, 2020 | 4.88 Mn |
| Sep 30, 2020 | 4.77 Mn |
| Dec 31, 2014 | 3.06 Mn |